The Short-term Rise and Fall of AMGEN Inc. (AMGN) Stock

AMGEN Inc. [AMGN] stock is trading at $265.51, down -0.66%. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The AMGN shares have lost -1.37% over the last week, with a monthly amount drifted -2.22%, and not seem to be holding up well over a long-time horizon.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

From an analyst’s perspective:

Previously, Leerink Partners downgraded its rating to Market Perform on February 07, 2024, and dropped its price target to $318. On December 21, 2023, upgrade upgraded it’s rating to Buy and revised its price target to $320 on the stock. BMO Capital Markets upgraded its rating to a Outperform and increased its price target to $326 on December 19, 2023. RBC Capital Mkts upgraded its rating to a Outperform and raised its price target to $300 on December 12, 2023. Deutsche Bank started tracking with a Hold rating for this stock on November 09, 2023, and assigned it a price target of $240. In a note dated November 02, 2023, Truist upgraded an Buy rating on this stock and boosted its target price from $260 to $320.

AMGEN Inc. [AMGN] stock has fluctuated between $211.71 and $329.72 over the past year. Currently, Wall Street analysts expect the stock to reach $257.26 within the next 12 months. AMGEN Inc. [NASDAQ: AMGN] shares were valued at $265.51 at the most recent close of the market. An investor can expect a potential drop of -3.11% based on the average AMGN price forecast.

Analyzing the AMGN fundamentals

AMGEN Inc. [NASDAQ:AMGN] reported sales of 28.01B for the trailing twelve months, which represents a growth of 20.42%. Gross Profit Margin for this corporation currently stands at 0.7% with Operating Profit Margin at 0.32%, Pretax Profit Margin comes in at 0.28%, and Net Profit Margin reading is 0.24%. To continue investigating profitability, this company’s Return on Assets is posted at 0.07, Equity is 1.03 and Total Capital is 0.12. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of10.37.

Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 262.93 points at the first support level, and at 260.34 for the second support level. However, for the 1st resistance point, the stock is sitting at 269.51, and for the 2nd resistance point, it is at 273.51.

Ratios To Look Out For

For context, AMGEN Inc.’s Current Ratio is 1.65. In addition, the Quick Ratio stands at 1.13 and the Cash Ratio stands at 0.6. Considering the valuation of this stock, the price to sales ratio is 5.08, the price to book ratio is 22.81 and price to earnings (TTM) ratio is 21.27.

Transactions by insiders

Recent insider trading involved Grygiel Nancy A., SVP & CCO, that happened on Dec 04 ’23 when 2096.0 shares were sold. EVP, Gen. Counsel & Secy., Graham Jonathan P completed a deal on Nov 08 ’23 to sell 10000.0 shares. Meanwhile, 10% Owner AMGEN INC bought 1.76 million shares on Sep 19 ’23.

Related Posts